Cross-Border Compliance: New Cosmetic Rules in China, US, EU, ASEAN

What Changed in China for Cross-Border Compliance?

China restructured its raw material inventory, expanded electronic labeling, and launched a three-year quality management action plan, and all three changes affect how an overseas brand files and labels a product. The raw material change matters most for formulation timing, because ingredient status now determines which documentation a filing needs.

For a brand sourcing from a contract manufacturer, the practical effect is that ingredient selection and filing strategy have to happen together rather than in sequence. A formula chosen without checking the current ingredient lists can fail at the filing stage, after the prototype and stability work are already paid for.

Raw material inventory restructured into two lists

The Chinese authority split its inventory of existing cosmetic ingredients into two lists and expanded the number of ingredients used in marketed products substantially. The practical consequence is that each ingredient now carries a sub-list identity, and that identity determines whether additional safety assessment documents are required.

For a product brief, this changes the checkpoint order. Ingredient screening now happens before prototype selection rather than after, because a promising active can add filing documents that shift the launch date.

Electronic labeling pilot expanded to six regions

Electronic labeling allows a product to carry Chinese label information in electronic form instead of printing full Chinese text on the physical package. The pilot covers six regions for a three-year period, and it applies to domestic products and imports in those regions.

The benefit is real but conditional. A shorter printed label reduces version management cost across frequent launches, but the manufacturer needs label management software that can publish and maintain the electronic version. Ask about that capability before planning around the pilot.

Three-year quality management action plan in effect

A three-year action plan on production quality management requires companies to self-inspect their quality system documents, confirm that production matches what was filed, and verify raw material compliance. Enforcement in the same period has included orders to halt production and, at the severe end, revocation of production licenses.

For a brand, this turns documentation completeness into a sourcing question. A manufacturer that cannot produce batch records, raw material traceability documents, and quality system files on demand carries a compliance risk that transfers to your product listing.

What Does MoCRA Enforcement Require From an Overseas Manufacturer?

MoCRA requires every cosmetic manufacturing facility to register with the FDA, every product to be listed, and the responsible party to hold adequate safety substantiation. For a brand sourcing overseas, the manufacturer's registration status becomes part of your own listing requirement, so it is a sourcing checkpoint rather than a paperwork detail.

DEVA Skincare holds US FDA cosmetic manufacturer registration granted in 2023, along with ISO 22716 and GMPC certification. That registration can be referenced when your product listing is filed.

Facility registration renewal on a two-year cycle

Facility registration must be renewed every two years from the initial registration date. The FDA provides renewal reminders through its Cosmetics Direct system. A registration that lapses breaks the product listing that references it, and the failure appears at the point of sale rather than at the factory.

Fragrance allergen labeling in the rulemaking pipeline

MoCRA directs the FDA to establish fragrance allergen labeling requirements, and the proposed rule has moved through a delayed schedule. The final rule will land after the proposal stage, which gives manufacturers time to prepare but not unlimited time.

The preparation that matters is data, not labels. Obtaining complete allergen component data from fragrance suppliers takes significant lead time, so a manufacturer should confirm that suppliers can provide full technical data sheets listing allergen components before the rule is final. DEVA Skincare screens the full ingredient list against global regulatory databases at the prototyping stage, which catches fragrance data gaps before a formula is fixed.

PFAS oversight advancing at federal and state level

The FDA has identified potential restrictions on PFAS-containing cosmetics as a regulatory focus, and multiple US states have introduced their own restrictions, producing a fragmented set of rules rather than a single national one.

The affected products are the ones making waterproof or long-wear claims, because PFAS chemistry sits behind some of those performance profiles. A manufacturer working on such a product should verify PFAS content and prepare substitute systems before state rules firm up.

Which EU Ingredient Changes Take Effect in 2026?

Two EU changes carry hard dates, and both affect anti-aging and sunscreen lines.

Regulation (EU) 2026/78 and the prohibited substance list

Regulation (EU) 2026/78 updates Regulation (EC) No 1223/2009 and applies from 1 May 2026. It moves newly classified substances into the prohibited list in Annex II and shifts some materials into the restricted list in Annex III with concentration conditions.

The critical detail is the absence of a transition period. After 1 May 2026, a product containing a newly prohibited ingredient cannot be supplied to the EU market, and existing retail inventory must be cleared as well. That makes a portfolio review a mandatory step rather than a planned improvement, and the review needs to run against full INCI lists rather than product names.

Retinol concentration limits now fully enforced

Concentration limits for retinol, retinyl acetate, and retinyl palmitate apply to products on the market. Retinol is capped at 0.3% for face products and 0.3% for body products, and is prohibited in products for children and pregnant users. Only the retinol entries with a confirmed limit are listed here; verify each retinol ester against the current annex before filing.

For an anti-aging line built around retinol, the limit is a formulation ceiling rather than a labeling note. A formula developed at 0.5% retinol needs reformulation to 0.3% or below, and the efficacy evidence has to be rebuilt at the lower loading.

EU change	Reference	Applies from	What a brand must do
Newly classified substances moved to the prohibited list	Regulation (EU) 2026/78	1 May 2026	Cross-check full INCI lists and clear existing retail inventory
Materials moved to the restricted list with concentration conditions	Regulation (EU) 2026/78	1 May 2026	Verify concentration against Annex III conditions
4-MBC banned from sale as a UV filter	Regulation (EU) 2026/78	1 May 2026	Reformulate sunscreen systems using 4-MBC
Homosalate limited to facial products at 7.34%	Regulation (EU) 2022/2195	Off market from 1 January 2025, off shelf from 1 July 2025	Replace or reformulate body sunscreen using homosalate
Retinol capped at 0.3% in face and body products	Regulation (EC) No 1223/2009 as amended	Fully enforced	Reformulate above-limit retinol products and rebuild efficacy data

How Do ASEAN Markets Diverge From One Harmonized Framework?

ASEAN operates through the ASEAN Cosmetic Directive, which harmonizes the ingredient annexes across member states. Notification still happens country by country, and the implementation timeline differs between members even when the underlying ingredient list is the same.

Aspect	Harmonized under the ASEAN Cosmetic Directive	Country-level in practice
Ingredient lists	Annexes are harmonized across members	Adoption timing of updates varies by member state
Notification	A common notification framework applies	Each member runs its own submission portal and document set
Labeling language	Requirements are defined in the directive	English or the local official language, depending on the member
Certificate of Free Sale	Not covered by the directive	Some members require notarized documents
Aerosol and pressurized products	Not covered by the directive	Additional hazardous goods permits and local labeling

The practical rule is to sequence market entry rather than file everywhere at once. A manufacturer with multi-market filing experience can tell you which member state will clear first and which one needs documents that take longer to obtain.

What Does a Cross-Border Compliance Review Cover?

A structured review covers four layers, and skipping any one of them leaves a gap that shows up at customs or at the filing desk.

Layer	What it covers	Output	When it runs
Design for compliance	Ingredient screening against every target market list before the formula is fixed	Clearance report on the full ingredient set	Before prototype selection
Documentation build	Product Information File, safety report, facility registration details, product listing records	Complete dossier per market	After the formula is frozen
Claim review	Claim wording against the common criteria, the claims guide, and the prohibited term lists	Approved claim list per market	Before artwork is signed off
Dynamic tracking	Monitoring of annex updates, new restrictions, and enforcement dates	Change notice with an affected-product list	Continuously after launch

The first layer is where the cost difference is decided. Screening before the prototype costs a formulation meeting. Screening after the formula is frozen costs a reformulation plus a repeat stability cycle, plus the panel work that has to be redone at the new loading.

DEVA Skincare runs this screening at the prototyping stage against global regulatory databases, which flags restricted substances before the formula is locked. A regulatory affairs team compiles the Product Information File, coordinates the safety report with licensed assessors, and handles notification through the Cosmetic Products Notification Portal for EU-bound products.

How Long Does Cross-Border Compliance Work Take?

Work package	Duration	Can it run in parallel	What it blocks
Ingredient screening and filing strategy	Part of the 1-week sampling stage	No, it precedes the prototype	Prototype selection
Formula development and stability testing	4 weeks	Yes, with in-vitro panel work	The safety report
In-vitro panel testing	4 weeks	Yes, with stability work	Claim substantiation
28-day human use test	4 weeks	After safety screening	Specific efficacy claims
SPF and water resistance testing	4 weeks	After the formula is frozen	Sunscreen claims
Product Information File and safety report	Runs across the above	Yes	EU notification
Sample approval	1 week	No	Production
Mass production	6 weeks after sample approval	No	Launch date

A product targeting China, the EU, and the US with a claim that needs a human study should plan roughly one quarter from an approved brief to a shippable batch, with the stability, panel, and documentation streams overlapping. The mistake that pushes a launch past that window is a late claim change, because a new claim can require a new endpoint rather than an extra visit.

What Should a Brand Verify Before Signing With an OEM?

Six checks cover the questions that a compliance problem will expose later.

Facility registration and certification. Ask for FDA cosmetic manufacturer registration details, ISO 22716, and GMPC documentation, and confirm the registration renewal date. MoCRA ties your product listing to the manufacturer's registration, and DEVA Skincare holds registration granted in 2023 with renewal tracked on the two-year cycle.

Ingredient screening timing. Ask whether screening happens before the prototype or after the formula is fixed. Screening at prototyping is what prevents a reformulation cycle, and DEVA Skincare runs it against global regulatory databases before the formula is locked.

Documentation ownership. Ask who drafts the Product Information File and the safety report, and whether the manufacturer has an in-house regulatory affairs function or outsources the whole file. An in-house team can answer an authority query without a third-party delay.

Testing capacity. Ask how many test protocols run in-house and which ones go to third parties. DEVA Skincare runs 150 efficacy and safety test protocols covering cell efficacy and toxicity, CAM irritation, melanin inhibition, and preservative challenge, with 72 inspection and process control steps in production. Six laboratories cover cell testing, product efficacy evaluation with VISIA imaging across 12 skin indicators, plant extraction and fermentation, active ingredient analysis with HPLC, gas chromatography and UV-Vis, packaging testing with xenon lamp aging, and heavy metal testing.

Manufacturing capacity for the market you are entering. DEVA Skincare operates four sites: the Guangzhou headquarters at 20,000 square meters with nine lines, a second Huangpu site at 8,000 square meters with seven lines, a new Huangpu headquarters at 46,000 square meters with twelve lines, and an Indonesia site at 10,000 square meters with five lines. Combined monthly capacity exceeds 20 million units, and the 100,000-class GMPC cleanrooms plus a CNAS-standard core laboratory sit inside that footprint.

Certificates held for your category. DEVA Skincare holds 22 special cosmetics certificates with 21 more under application, more than 70 granted patents, and 5,000 or more mature formulas, supported by 30 or more R&D engineers, 30 or more industry experts, and research partnerships with six universities.

Send your target market list, product category, and intended claims through the inquiry form below, and our regulatory affairs team will map the cross-border compliance path for your product line before the formula is fixed.

When does Regulation (EU) 2026/78 take effect?

Regulation (EU) 2026/78 updates Regulation (EC) No 1223/2009 and applies from 1 May 2026. It moves newly classified substances into the prohibited list in Annex II and shifts some materials into the restricted list in Annex III. There is no transition period, so a product containing a newly prohibited ingredient cannot be supplied to the EU after that date and existing retail inventory must be cleared.

What are the EU retinol concentration limits?

Retinol is capped at 0.3% for face products and 0.3% for body products, and is prohibited in products intended for children and pregnant users. The limits apply to products on the market. A formula developed above the ceiling needs reformulation, and the efficacy evidence supporting a claim has to be rebuilt at the lower loading rather than carried over.

How often must a cosmetic facility registration be renewed?

Facility registration must be renewed every two years from the initial registration date. The FDA provides renewal reminders through its Cosmetics Direct system. If the registration lapses, the product listing that references it breaks, and the failure appears at the point of sale rather than at the factory, which is why the renewal date belongs in your sourcing checklist.

Which markets ban 4-MBC and from when?

4-MBC is banned from sale in the EU from 1 May 2026 under Regulation (EU) 2026/78. It is not on the monograph list for the US market, and it is not on the permitted filter list in China. A sunscreen system built around 4-MBC needs reformulation rather than a labeling change, and the replacement filter must clear every target market at once.

How long does cross-border compliance work take?

Roughly one quarter from an approved brief to a shippable batch for a product targeting China, the EU, and the US with a claim that needs a human study. Ingredient screening precedes the prototype, sampling takes one week, each test protocol takes about four weeks, and mass production takes six weeks after sample approval. The stability, panel, and documentation streams can run in parallel.

What is the MOQ for a compliance-ready product line?

Standard MOQ is 5,000 units, with aluminum cans starting at 10,000 units, sheet masks 50,000 units, and ampoules 200,000 units. Sampling takes one week and mass production takes six weeks after sample approval. MOQ does not change with the compliance scope, but the number of formula variants does, since different markets can require different filter, preservative, or claim sets.